Hiring?
Logo

CellX Technologies

location_on

North East, USA

Short Summary

Cell X Technologies, Inc. is a spin-out of the Cleveland Clinic by Dr George Muschler. “Cell X”, is an automated robotic cell processing platform, designed and engineered in collaboration with Parker Hannifin Corporation.

Overview

Target
US$2,500,000
Minimum
US$10,000
Investment Raised
US$800,000
Previous Rounds US$1,500,000
Stage Profitable
Investor Role Silent

Highlights

  • Cell X Technologies, Inc. is a spin-out of the Cleveland Clinic.
  • Developed by Dr. George Muschler and Dr. Kimerly Powell
  • Designed and engineered in collaboration with Parker Hannifin Corporation
  • Cell X is the only fully robotic culture automation and analysis system
  • An immediate market opportunity of more than $250M, with expanding market
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Pro
0% raised

Next-Gen. Collaboration

location_on North East, USA

SABHAE is an advanced all-in-one collaboration suite that is unique, smart, and highly-capable compared to other top collaboration tools currently present in the market. We have designed this platform from the ground up for usage across industries.

US$ 3,000,000

Target

US$ 25,000

Min per Investor

Pro
5% raised

Treating Osteoporosis

location_on West, USA

We improve skeletal health to extend lifespan and increase quality of life

US$ 1,000,000

Target

US$ 100

Min per Investor

Pro
0% raised

Thc/cbd Lab Equipment

location_on South East, USA

US$ 250,000

Target

US$ 250,000

Min per Investor

load one similar proposal